Iylon Precision Oncology for Individualized Cancer Care
Precise, Proactive, Patient Specific
Your Search for Right Treatment Ends Here
About
Iylon brings together, World Leaders in Precision Oncology to provide Individualised Cancer Care and Cancer Treatment Recommendations.
Advances in cancer diagnosis and treatment have significantly increased cancer patient survival. To help cancer patients around the world, we at Iylon, bring together experts in Precision Oncology to comprehensively evaluate genomic, pathology, laboratory, and radiology reports and suggest a customized strategy for the patient. Our goal is to bring the right expert to the right patient at the right dose and at the right time.
Our Services
Each cancer patient is unique and deserves individualised care.
International Precision Oncology Consultation
Thanks to Precision Oncology, cancer is no longer considered life-threatening. Iylon Precision Oncology has identified with pioneers in the field, who will review clinical and genomic information and provide individualized, evidence-based optimal treatment plan for each patient.
International General Oncology Consultation
No genomic testing yet? You can still get a General Oncology Consultation. To avoid delay in treatment, Iylon Precision Oncology will review the case as part of its International General Oncology Consultation, get input from international experts who will provide actionable recommendations to your clinician for immediate treatment.
International Virtual Oncology Consultation
Iylon’s virtual consultation provides personalized, evidence based optimal precision treatment recommendations for cancer patients from experts to the patients clinicians.
International Consultation with Live Panel of Experts
Iylon offers its flagship, first of its kind second opinion service in the world geared towards the best minds teaming up virtually for a single patient. Our top experts in radiology, pathology, molecular oncology, medical oncology, and genomics team up to discuss the patient case details and offer their recommendations to the patient’s clinician.
What Our Patients Say
I was diagnosed with advanced breast cancer that was Her2 positive. I was given two targeted therapy drugs along with chemotherapy. Today I am fortunate to have no...
My lung cancer had traveled to the brain but I was lucky to have an EGFR mutation which could be targeted with an oral drug that could reach my brain. Today I am in...
Immunotherapy worked effectively because my tumor was PDL1+; I strongly recommend any cancer patient opt for precision oncology.
Advisors-Where the Passion begins
Iylon Precision Oncology is proud to have the world’s best Precision Oncologists on our team Their experience, capability and passion form the foundation of our success in serving our clients.
Dr.Scott Kopetz,MD,PhD
Professor and Deputy Chair
Department of Gastrointestinal Medical Oncology
MD Anderson Cancer Center
Houston, Texas, USA
Dr. Shirish Gadgeel
Chief of Division of Haematology and Oncology
Henry Ford Cancer Institute
Houston, Texas, USA
Dr. Sendurai A. Mani, PhD
Professor Division of Pathology – Lab Medicine Department of Translational Molecular Pathology MD Anderson Cancer Centre
Houston, Texas, USA
Dr. Balazs Halmos, MD, MS
Director of Clinical Cancer Genetics
Director of Thoracic Medical Oncology Montefiore Health Systems
NY, USA
Dr.Vivek Subbiah,MD
Clinical Medical Director
Clinical Center for Targeted Therapy
The University of Texas MD Anderson
Cancer Center
Houston, Texas, USA
Dr. Ken ’O’Byrne, FRACP, FRCPA, MD
Professor Medical Oncology
Princess Alexandra Hospital, Queensland University of Technology Translational Research Institute (TRI)
Brisbane, Australia
Dr. Sewanti Limaye, MD, MS
Director of Precision Oncology
Director of Clinical and Translational Oncology Research Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute
Mumbai,India
Dr. Padmaja Ganapathy, PhD, MBA
CEO, Iylon Precision Oncology
Princeton, NJ, USA.
Dr. Jochen H Lorch, MD, MSc
Director Thyroid Center
Director Endocrine Cancer Center
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA, USA
Dr. Paul Hofman, MD, PhD
Academic Director
Laboratory of Clinical and Experimental Pathology (LPCE) Université Côte d’Azur, Louis Pasteur Hospital
Nice, France
Patrick Y. Wen, MD
Professor of Neurology, Harvard Medical School
Director, Center for Neuro-Oncology
Harvard Medical School, Dana-Farber Cancer Institute
Boston, MA
USA
Richard Lee, MD, PhD
Assistant Physician, Department of Medicine
Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Massachusetts General Hospital
Boston, MA
USA
Dr. Anil K. Sood, MD
Vice Chair for Translational Research
Department of Gynecologic Oncology & Reproductive Medicine
MD Anderson Cancer Center
Houston, Texas, USA
Dr. Razelle Kurzrock, MD
Associate Director & Clinical Science
Director Center for Personalized Cancer Therapy
Moores Cancer Center
UCSD, San Diego, CA,USA.
Dr. Massimo Cristofanilli, MD
Associate Director of Translational Research and Precision Medicine
The Robert H Lurie Comprehensive Cancer Center
Chicago, IL, USA
Dr. Swaminathan P. Iyer, M.D.
Department of Lymphoma-Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas
USA
How it Works
Precision Oncology combines clinical, pathological, genomic, and other health information and facilitates personalized cancer treatment for each patient.
Download the App
Iylon Oncology services now available at convenience on mobile. Download the app now.
Please complete this form and we will direct your enquiry to the appropriate Iylon team member.
USA: +1-617-299-0904
India: +91-7777013173
+91-7710008952
Subscribe